The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Chemical genomic screening for methylation‐silenced genes in gastric cancer cell lines using 5‐aza‐2′‐deoxycytidine treatment and oligonucleotide microarray
Open accessAbstract
To identify novel methylation‐silenced genes in gastric cancers, we carried out a chemical genomic screening, a genome‐wide search for genes upregulated by treatment with a demethylating agent, 5‐aza‐2′‐deoxycytidine (5‐aza‐dC). After 5‐aza‐dC treatment of a gastric cancer cell line (AGS) 579 genes were upregulated 16‐fold or more, using an oligonucleotide microarray with 39 000 genes. From these genes, we selected 44 known genes on autosomes whose silencing in gastric cancer has not been reported. Thirty‐two of these had CpG islands (CGI) in their putative promoter regions, and all of the CGI were methylated in AGS, giving an estimated number of 421 ± 75 (95% confidence interval) methylation‐silenced genes. Additionally, we analyzed the methylation status of 16 potential tumor‐related genes with promoter CGI that were upregulated four‐fold or more, and 14 of these were methylated in AGS. Methylation status of the 32 randomly selected and 16 potential tumor‐related genes was analyzed in 10 primary gastric cancers, and 42 genes (ABHD9, ADFP, ALDH1A3, ANXA5, AREG, BDNF, BMP7, CAV1, CDH2, CLDN3, CTSL, EEF1A2, F2R, FADS1, FSD1, FST, FYN, GPR54, GREM1, IGFBP3, IGFBP7, IRS2, KISS1, MARK1, MLF1, MSX1, MTSS1, NT5E, PAX6, PLAGL1, PLAU, PPIC, RBP4, RORA, SCRN1, TBX3, TFAP2C, TNFSF9, ULBP2, WIF1, ZNF177 and ZNF559) were methylated in at least one primary gastric cancer. A metastasis suppressor gene, MTSS1, was located in a genomic region with frequent loss of heterozygosity (8q22), and was expressed abundantly in the normal gastric mucosa, suggesting its role in gastric carcinogenesis. (Cancer Sci 2006; 97: 64 –71)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
Self-citationSuzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
Jones, R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg962 · Cited by 828
Detection and interpretation of altered methylation patterns in cancer cells
Ushijima, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1571 · Cited by 483
Self-citationToyota, M., Ho, C., Ahuja, N., Jair, K. W., Li, Q., Ohe-Toyota, M., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 464
Yamashita, K., Upadhyay, S., Osada, M., Hoque, M. O., Xiao, Y., Mori, M., Sato, F., Meltzer, S. J., & Sidransky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00215-5 · Cited by 340
Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C. J., Cameron, J. L., Hruban, R. H., & Goggins, M. (2003) · PubMed · Cited by 336
Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer
Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J., & Hermeking, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4407 · Cited by 286
Ushijima, T., & Sasako, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00033-9 · Cited by 282
Self-citationWiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K. M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P. D., Dietel, M., Schäfer, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63010-6 · Cited by 275
Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer
Mazieres, J., He, B., You, L., Xu, Z., Lee, A. Y., Mikami, I., Reguart, N., Rosell, R., McCormick, F., & Jablons, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1389 · Cited by 271
Ge, X., Yamamoto, S., Tsutsumi, S., Midorikawa, Y., Ihara, S., Wang, S. M., & Aburatani, H. (2005) · Genomics · doi:10.1016/j.ygeno.2005.04.008 · Cited by 248
Butt, A. J., Firth, S. M., King, M. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908888199 · Cited by 214
Jones, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn993 · Cited by 209
Liang, G., Gonzales, F. A., Jones, P. A., Orntoft, T. F., & Thykjær, T. (2002) · PubMed · Cited by 205
Identification of silencing of nine genes in human gastric cancers.
Kaneda, A., Kaminishi, M., Yanagihara, K., Sügimura, T., & Ushijima, T. (2002) · PubMed · Cited by 196
Self-citationSunaga, N., Miyajima, K., Suzuki, M., Sato, M., White, M. A., Ramirez, R. D., Shay, J. W., Gazdar, A. F., & Minna, J. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3941 · Cited by 178
Aberrant Methylation and Silencing of theBNIP3Gene in Colorectal and Gastric Cancer
Murai, M., Toyota, M., Suzuki, H., Satoh, A., Sasaki, Y., Akino, K., Ueno, M., Takahashi, F., Kusano, M., Mita, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1021.11.3 · Cited by 175
MIM, a Potential Metastasis Suppressor Gene in Bladder Cancer
Lee, Y.-G., Macoska, J. A., Korenchuk, S., & Pienta, K. J. (2002) · Neoplasia · doi:10.1038/sj.neo.7900231 · Cited by 170
Kaneda, A., Wakazono, K., Tsukamoto, T., Watanabe, N., Yagi, Y., Tatematsu, M., Kaminishi, M., Sugimura, T., & Ushijima, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1543 · Cited by 163
Self-citationEpigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer.
Satoh, A., Toyota, M., Itoh, F., Sasaki, Y., Suzuki, H., Ogi, K., Kikuchi, T., Mita, H., Yamashita, T., Kojima, T., et al. (2003) · PubMed · Cited by 163
MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcriptionPreprint
Callahan, C. A., Ofstad, T. A., Horng, L. M.-S., Wang, J. K., Zhen, H. H., Coulombe, P. A., & Oro, A. E. (2004) · Genes & Development · doi:10.1101/gad.1221804 · Cited by 157
Esteller, M., Guo, M., Moreno, V. R., Peinado, M. A., Capellá, G., Galm, O., Baylin, S. B., & Herman, J. G. (2002) · PubMed · Cited by 153
Hagihara, A., Miyamoto, K., Furuta, J., Hiraoka, N., Wakazono, K., Seki, S., Fukushima, S., Tsao, M., Sügimura, T., & Ushijima, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207783 · Cited by 140
Self-citationDiverse Biological Effect and Smad Signaling of Bone Morphogenetic Protein 7 in Prostate Tumor Cells
Yang, S., Zhong, C., Frenkel, B., Reddi, A. H., & Roy‐Burman, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0289 · Cited by 138
Weiss, M. M., Kuipers, E. J., Postma, C., Snijders, A. M., Pinkel, D., Meuwissen, S. G. M., Albertson, D. G., & Meijer, G. A. (2004) · Analytical Cellular Pathology · doi:10.1155/2004/454238 · Cited by 138
Hanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., 谷山真由美, Nakamura, S., Uemura, M., Takuma, Y., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00736-4 · Cited by 126
Abdollahi, A., Pisarcik, D. A., Roberts, D., Weinstein, J. K., Cairns, P., & Hamilton, T. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210361200 · Cited by 123
Bilanges, B., Varrault, A., Basyuk, E. I., Rodríguez, C., Mazumdar, A., Pantaloni, C., Bockaert, J., Theillet, C. G., Spengler, D., & Journot, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202933 · Cited by 104
Pakneshan, P., Xing, R. H., & Rabbani, S. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0973com · Cited by 94
Wang, W. T., Hüper, G., Guo, Y., Murphy, S. K., Olson, J. A., & Marks, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208464 · Cited by 94
Allelotype of gastric adenocarcinoma.
Yustein, A. S., Harper, J., Petroni, G. R., Cummings, O. W., Moskaluk, C. A., & Powell, S. M. (1999) · PubMed · Cited by 93
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma
Chan, A. S. W., Tsui, W. Y., Chen, X., Chu, K., Chan, T. L., Chan, A. S. Y., Li, R., So, S. K., Yuen, S. T., & Leung, S. Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206799 · Cited by 92
Komatsu, S., Okazaki, Y., Tateno, M., Kawai, J., Konno, H., Kusakabe, M., Yoshiki, A., Muramatsu, M., Held, W. A., & Hayashizaki, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1937 · Cited by 72
Decreased Fidelity in Replicating CpG Methylation Patterns in Cancer Cells
Ushijima, T., Watanabe, N., Shimizu, K., Miyamoto, K., Sügimura, T., & Kaneda, A. (2005) · Cancer Research · doi:10.1158/0008-5472.11.65.1 · Cited by 53
Self-citationEpigenetic Silencing of Cellular Retinol-Binding Proteins in Nasopharyngeal Carcinoma
Kwong, J., Lo, K. W., Chow, L. S., To, K., Choy, K. W., Chan, F. L., Mok, S. C., & Huang, D. P. (2005) · Neoplasia · doi:10.1593/neo.04370 · Cited by 47
Xing, R. H., & Rabbani, S. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990505)81:3<443::aid-ijc19>3.0.co;2-t · Cited by 46
Cited by
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
Marchitti, S. A., Brocker, C., Stagos, D., & Vasiliou, V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.697 · Cited by 805
Jetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 673
Nguyen, A., Rauch, T. A., Pfeifer, G. P., & Hu, V. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-154484 · Cited by 350
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie-Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 323
The roles and regulation of TBX3 in development and disease
Khan, S. F., Damerell, V., Omar, R., Du Toit, M., Khan, M., Maranyane, H. M., Mlaza, M., Bleloch, J., Bellis, C., Sahm, B. D. B., et al. (2020) · Gene · doi:10.1016/j.gene.2019.144223 · Cited by 99
“The authors showed that in this gastric cancer cell line, but not in 5 other gastric cancer cell lines tested, methylation of the CpG island in the 5′ region of the TBX3 gene effectively silenced its expression (Yamashita et al., 2006).”
Background
Metadata
- Authors
- Yamashita, S., Tsujino, Y., Moriguchi, K., Tatematsu, M., & Ushijima, T.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2005-12-21
- Volume
- 97
- Issue
- 1
- Pages
- 64-71
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W1969179633
- Cited by
- 253
- References
- 41
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.